Back to home

About Serenoty Labs

Serenoty is a research platform that gets out of your way so you can focus on actual research. We built it because we were drowning in PDFs, scattered annotations, and repetitive tasks that consumed our time instead of advancing scientific discovery.

Modern tools can ethically accelerate research workflows without compromising scientific rigor. Serenoty enhances human intelligence, preserving creativity and critical thinking while giving researchers the efficiency they need.

Built for Systematic Literature Reviews

Systematic reviews and systematic literature reviews are supposed to be rigorous — but in practice, a lot of time gets burned on file wrangling, duplicate handling, scattered notes, and manual “where did that number come from?” moments. Serenoty is designed to keep the workflow structured end-to-end, so you can move faster without weakening methodology.

Use Serenoty to organize papers in one place, screen and tag studies consistently, and keep inclusion/exclusion decisions traceable. When it’s time to extract evidence, you can capture key details in a repeatable way (rather than reinventing a spreadsheet for every project), and keep your citations linked to the exact source context.

The goal is simple: make systematic review work feel less like administration and more like science. We help teams maintain an audit trail, stay reproducible, and produce outputs that are easier to summarize, report, and share — including PRISMA-style documentation and clean handoffs between collaborators.

Smart, but basic

A clean way to route papers into the right place, preview what matters, and find evidence fast — without your library turning into chaos.

SmartSystematic reviewsClinical trialsGuidelinesMethods
Routed based onkeywordsjournalprojectauthorrecent routing

Smart folders

Organize documents with intelligent categorization.

PRISMA 2020 statement

Guidelines

Guideline

CVOT meta-analysis (2024)

Systematic reviews

Review

REWIND trial — cardiovascular outcomes

Clinical trials

RCT

Preview panel

Quick access to document details and metadata.

12 pages

REWIND trial — cardiovascular outcomes

Added 2d ago · 3 highlights · 1 note

Year: 2024Design: RCTJournal: NEJM
semaglutideMACET2DASCVD

PMID: 40123456 · + more

Search + filters

18 results

2020–2025RCTCardiologyHigh relevance

Top match

Match

Meta-analysis: GLP‑1 RAs & MACE outcomes (2024)

“…consistent reduction in 3‑point MACE across CVOTs with low heterogeneity…”

Result

RCT0.92

SELECT trial: semaglutide in obesity

…reduced composite CV outcomes in adults with overweight/obesity…

Result

RCT0.88

LEADER trial: liraglutide CV outcomes

…lower risk of major adverse CV events vs placebo…

If what we've described sounds familiar, if you've felt that same frustration of knowing there's a better way, we'd genuinely love for you to try Serenoty.

We're not perfect, and we're still learning and building. But we're building it for you, because we've been where you are. Every feature comes from a real frustration we've experienced or heard about from other researchers.

Thanks for reading our story.

The Serenoty Team

Take Serenoty Labs for a spin